Body mass index and the risk for crohn's disease and ulcerative colitis: Data from a european prospective cohort study (The IBD in EPIC Study)

American Journal of Gastroenterology

Volumn 108, Issue 4, 2013, Pages 575-582

  Chan, Simon S M ^a,b   Luben, Robert ^c   Olsen, Anja ^d   Tjonneland, Anne ^d   Kaaks, Rudolf ^e   Teucher, Birgit ^e   Lindgren, Stefan ^f   Grip, Olof ^f   Key, Timothy ^g   Crowe, Francesca L ^g   Bergmann, Manuela M ^h   Boeing, Heiner ^h   Hallmans, Göran ⁱ   Karling, Pontus ⁱ   Overvad, Kim ^j   Palli, Domenico ^k   Masala, Giovanna ^k   Kennedy, Hugh ^b   Vanschaik, Fiona ^l   Bueno De Mesquita, Bas ^l,m   Oldenburg, Bas ^l   Khaw, Kay Tee ^c   Riboli, Elio ⁿ   Hart, Andrew R ^a,b   more..

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

ⁱ UMEÅ UNIVERSITY   (Sweden)

^j AARHUS UNIVERSITY   (Denmark)

^k Cancer Prevention and Research Institute   (Italy)

^l UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^m NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁿ IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; ENERGY INTAKE; EUROPE; EXERCISE; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; YOUNG ADULT;

EID: 84875918270     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.453     Document Type: Article

References (35)

1. Cosnes J, Gower-Rousseau C, Seksik P et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-94.
2. Visiongain. Inflammatory Bowel Disease: World Market 2010-2025. Visiongain: London, 2010.
3. Gustafson B, Hammarstedt A, Andersson CX et al. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 2276-83.
4. Hotamisligil GS, Arner P, Caro JF et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-15.
5. Greenfield JR, Samaras K, Jenkins AB et al. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 2004; 109: 3022-8.
6. Poullis A, Foster R, Shetty A et al. Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2004; 13: 279-84.
7. Moreno-Navarrete JM, Sabater M, Ortegaega F et al. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesityassociated insulin resistance. PLoS One 2012; 7: e37160.
8. Riboli E, Hunt KJ, Slimani N et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113-24.
9. Wareham NJ, Jakes RW, Rennie KL et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003; 6: 407-13.
10. Day N, Oakes S, Luben R et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999; 80 (Suppl 1): 95-103.
11. Slimani N, Deharveng G, Unwin I et al. The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr 2007; 61: 1037-56.
12. Mendall MA, Gunasekera AV, John BJ et al. Is obesity a risk factor for Crohn's disease? Dig Dis Sci 2011; 56: 837-44.
13. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004; 25: 4-7.
14. Gummesson A, Carlsson LM, Storlien LH et al. Intestinal permeability is associated with visceral adiposity in healthy women. Obesity (Silver Spring, MD) 2011; 19: 2280-2.
15. Ouchi N, Parker JL, Lugus JJ et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011; 11: 85-97.
16. Blain A, Cattan S, Beaugerie L et al. Crohn's disease clinical course and severity in obese patients. Clin Nutr 2002; 21: 51-7.
17. Hass DJ, Brensinger CM, Lewis JD et al. The impact of increased body mass index on the clinical course of Crohn's disease. Clin Gastroenterol Hepatol 2006; 4: 482-8.
18. Long MD, Crandall WV, Leibowitz IH et al. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 2162-8.
19. Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond) 2008; 32 (Suppl 3): S56-9.
20. Seidell JC, Perusse L, Despres JP et al. Waist and hip circumferences have independent and opposite Effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr 2001; 74: 315-21.
21. Peyrin-Biroulet L, Gonzalez F, Dubuquoy L et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut 2012; 61: 78-85.
22. Zulian A, Cancello R, Micheletto G et al. Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease? Gut 2012; 61: 86-94.
23. Henriksen M, Jahnsen J, Lygren I et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut 2008; 57: 1518-23.
24. Ko GT, Liu KH, So WY et al. Cutoff values for central obesity in Chinese based on mesenteric fat thickness. Clin Nutr 2009; 28: 679-83.
25. Reas DL, Nygard JF, Svensson E et al. Changes in body mass index by age, gender, and socio-economic status among a cohort of Norwegian men and women (1990-2001). BMC Public Health 2007; 7: 269.
26. Purslow LR, Young EH, Wareham NJ et al. Socioeconomic position and risk of short-term weight gain: prospective study of 14, 619 middle-aged men and women. BMC Public Health 2008; 8: 112.
27. Lennard-Jones JE, Shivananda S. Clinical uniformity of inflammatory bowel disease a presentation and during the first year of disease in the north and south of Europe. EC-IBD Study Group. Eur J Gastroenterol Hepatol 1997; 9: 353-9.
28. Quezada SM, Cross RK. Association of age at diagnosis and ulcerative colitis phenotype. Dig Dis Sci 2012; 57: 2402-7.
29. Freeman HJ. Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients. Can J Gastroenterol 2007; 21: 363-6.
30. Heresbach D, Alexandre JL, Bretagne JF et al. Crohn's disease in the over-60 age group: a population based study. Eur J Gastroenterol Hepatol 2004; 16: 657-64.
31. Dandona P, Aljada A, Ghanim H et al. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 2004; 89: 5043-7.
32. Fontbonne A, Charles MA, Juhan-Vague I, et al., BIGPRO Study Group. The Effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. Diabetes Care 1996; 19: 920-6.
33. Isoda K, Young JL, Zirlik A et al. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler Thromb Vasc Biol 2006; 26: 611-7.
34. Stumvoll M, Nurjhan N, Perriello G et al. Metabolic Effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 550-4.
35. Rutgeerts P, D'Haens G, Hiele M et al. Appendectomy protects against ulcerative colitis. Gastroenterology 1994; 106: 1251-3.